These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 16580589)
1. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects. Dinkel RE; Barrett PH; Demant T; Parhofer KG Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins. Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484 [TBL] [Abstract][Full Text] [Related]
3. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. Campos H; Perlov D; Khoo C; Sacks FM J Lipid Res; 2001 Aug; 42(8):1239-49. PubMed ID: 11483625 [TBL] [Abstract][Full Text] [Related]
4. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431 [TBL] [Abstract][Full Text] [Related]
5. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799 [TBL] [Abstract][Full Text] [Related]
6. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype. Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888 [TBL] [Abstract][Full Text] [Related]
8. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. Khoo C; Campos H; Judge H; Sacks FM J Lipid Res; 1999 Feb; 40(2):202-12. PubMed ID: 9925648 [TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Chan DC; Watts GF; Nguyen MN; Barrett PH Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. Sehayek E; Eisenberg S J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Zheng C; Khoo C; Furtado J; Sacks FM Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524 [TBL] [Abstract][Full Text] [Related]
12. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study. Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160 [TBL] [Abstract][Full Text] [Related]
13. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Sacks FM Curr Opin Lipidol; 2015 Feb; 26(1):56-63. PubMed ID: 25551803 [TBL] [Abstract][Full Text] [Related]
14. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein C-III displacement of apolipoprotein E from VLDL: effect of particle size. Breyer ED; Le NA; Li X; Martinson D; Brown WV J Lipid Res; 1999 Oct; 40(10):1875-82. PubMed ID: 10508207 [TBL] [Abstract][Full Text] [Related]
16. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Chan DC; Watts GF; Barrett PH; O'Neill FH; Thompson GR Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090 [TBL] [Abstract][Full Text] [Related]
18. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde. Luc G; Fievet C; Arveiler D; Evans AE; Bard JM; Cambien F; Fruchart JC; Ducimetiere P J Lipid Res; 1996 Mar; 37(3):508-17. PubMed ID: 8728314 [TBL] [Abstract][Full Text] [Related]
19. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer. Bailhache E; Briand F; Nguyen P; Krempf M; Magot T; Ouguerram K Eur J Clin Invest; 2004 Aug; 34(8):527-34. PubMed ID: 15305886 [TBL] [Abstract][Full Text] [Related]
20. Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Tomiyasu K; Walsh BW; Ikewaki K; Judge H; Sacks FM Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1494-500. PubMed ID: 11557678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]